𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of receptor activator of NF-κB ligand (RANKL) mRNA in human multiple myeloma cells

✍ Scribed by Ulrike Heider; Ivana Zavrski; Christian Jakob; Katharina Bängeroth; Claudia Fleissner; Corinna Langelotz; Kurt Possinger; Lorenz C. Hofbauer; Volker Viereck; Orhan Sezer

Book ID
106123377
Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
258 KB
Volume
130
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The increased expression of receptor act
The increased expression of receptor activator of nuclear-κB ligand (RANKL) of multiple myeloma bone marrow stromal cells is inhibited by the bisphosphonate ibandronate
✍ Mireya Fernández; Ana M Pino; Paula Figueroa; Juan P Rodríguez 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

## Abstract The receptor activator of nuclear factor‐kappaB ligand (RANKL) and interleukin‐1beta are osteoclast activating factors which are abnormally expressed in bone marrow stromal cells and plasma cells of multiple myeloma patients. In this work we analyzed RANKL expression in human bone marro

Alkylating agents induce activation of N
Alkylating agents induce activation of NFκB in multiple myeloma cells
✍ Philipp Baumann; Sonja Mandl-Weber; Fuat Oduncu; Ralf Schmidmaier 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Multiple myeloma is still not curable and drug combination strategies are currently being evaluated in order to achieve high remission rates with tolerable toxicity. Bortezomib has been shown to exert inhibitory effects on NFB activity. NFB in turn is known to be activated by cytokines, growth facto